LLY vs. TSM: Eli Lilly vs. TSMC Stock Comparison

Performance

Cumulative Growth

Trailing Returns

Performance at a Glance

Risk

Drawdown

TSMC (TSM) has an aggressive beta of 1.38, indicating higher sensitivity to broad-market moves, while Eli Lilly (LLY) is defensive at 0.51 and tends to be less market-sensitive — they sit on opposite ends of the beta spectrum.

Risk at a Glance

Company Profile

Eli Lilly (LLY) is classified in the Health Care sector (Pharmaceuticals, Biotechnology & Life Sciences), whereas TSMC (TSM) belongs to Information Technology (Semiconductors & Semiconductor Equipment) — their GICS classifications point to very different parts of the market.

Eli Lilly (LLY) trades as ordinary local shares, while TSMC (TSM) trades as an ADR — compare with FX exposure, depositary-program fees, and dividend-withholding-tax differences in mind.

Valuation

TSMC (TSM) at 36.48 sits in the cheaper P/E ratio quartile, while Eli Lilly (LLY) at 40.32 is closer to its industry’s usual earnings multiple — a discount for TSM, though growth and earnings durability still matter.

TSMC (TSM) at 0.54 sits in the cheaper P/S ratio quartile while Eli Lilly (LLY) at 13.98 prices around its industry’s middle — TSM costs less per dollar of sales, though read it alongside growth and margins.

Measured against book value, both Eli Lilly (LLY) at 32.45 and TSMC (TSM) at 64.85 look expensive — each P/B ratio sits above its industry’s benchmark range.

Valuation at a Glance

Profitability

Both companies show strong equity returns, but Eli Lilly (LLY) at 107.46% is the standout with ROE above its industry range; TSMC (TSM) at 36.21% also sits in the top quartile.

Eli Lilly (LLY) at 34.99% keeps the most of each sales dollar — above its industry’s net margin range — and TSMC (TSM) at 46.51% also retains a top-quartile share.

Both Eli Lilly (LLY) at 49.39% and TSMC (TSM) at 58.11% convert sales into operating profit at a top-quartile rate, pointing to tighter cost discipline before financing and tax.

Profitability at a Glance

Growth

Revenue Growth

Revenue Growth at a Glance

EPS Growth

EPS Growth at a Glance

Financial Strength

TSMC (TSM) at 2.49 keeps current ratio within its industry’s typical mid-range, while Eli Lilly (LLY) at 1.50 runs in the tighter-liquidity quartile — a thinner cushion against current liabilities for LLY.

TSMC (TSM) at 0.18 carries an industry-typical debt-to-equity mix, while Eli Lilly (LLY) at 1.39 uses more debt funding than most peers.

Financial Strength at a Glance

Dividends

TSMC (TSM) at 0.90% earns its spot in the top quartile of its industry’s yields; Eli Lilly (LLY) at 0.61% is past the top of its own peer range — territory where a dividend-safety check matters more than the headline number.

Both pay out more than their industries’ typical bands, and LLY more so: TSMC (TSM) at 27.93% sits above the band, while Eli Lilly (LLY) at 22.13% exceeds every peer in its group.

Dividends at a Glance